RightFind Integrates with AVAYL MedPro Platform to Simplify Medical Information Workflows

Product Integration Streamlines Scientific Literature Access and Copyright Compliance for Users of MedPro’s AI-Powered Platform

DANVERS, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- CCC (Copyright Clearance Center), a pioneer in voluntary collective licensing, today announced an API-based integration of its software solution RightFind Enterprise^® with AVAYL’s MedPro, an AI-powered Medical Affairs workflow platform. Through this integration, medical information teams using MedPro’s user interface can gain secure access to published peer-reviewed scholarly literature and check applicable copyright licenses in RightFind directly within their MedPro AI-supported workflows, enabling them to conduct research more efficiently and responsibly.

RightFind Enterprise centralizes access to scientific literature and supports copyright compliance. It integrates rights information through applicable copyright licenses as supported in RightFind for medical information teams to verify how they can reuse published content. Other software solutions within the RightFind Suite from CCC include RightFind Cite It for simplified reference management, RightFind Navigate for personalized search of scientific content across internal and external data sources, and RightFind XML licensed article collections for internal AI projects.

AVAYL’s MedPro helps Medical Affairs professionals leverage AI for research, medical content authoring, and content management. It is fully tailored to the specific operational and regulatory needs of Medical Affairs teams, enabling AI speed with scientific rigor and compliance robustness.

“The Annual Copyright License and RightFind play a pivotal role in supporting Medical Information teams that rely on the solution for robust rights information and streamlined access to subscribed content and peer-reviewed publications essential for generating evidence-based medical responses,” said Lauren Tulloch, Vice President and Managing Director, CCC. “This collaboration demonstrates that innovation and copyright compliance can coexist.”

“Responsible AI innovation depends on collaboration across the ecosystem,” said Laura Zindler, Community & Engagement Lead, AVAYL. “Our partnership with CCC enables life science companies to harness AI for medical content authoring while facilitating copyright compliance, operational efficiency, and a responsible approach to patient safety. When we protect copyright, we also protect the scientific integrity of Medical Content.”

CCC advocates for copyright worldwide by engaging governments, stakeholders, and individuals through educational programming and resources from copyright organizations, with an emphasis on AI, Copyright & Licensing. Since 1978, CCC has supported content users by providing efficient licensing solutions for their content use. CCC’s non-exclusive voluntary collective rights licensing solutions include ACL for Business, Multinational Copyright License (MCL) for Business, ACL for Higher Education, AI Systems Training License, and ACL for Student Assessments. In addition to licensing solutions, CCC provides software solutions with integrated, one-stop access for users to request, receive, and pay for full-text content and permission to reuse content.

About CCC (Copyright Clearance Center)
A pioneer in voluntary collective licensing, CCC has been dedicated to advancing copyright, accelerating knowledge, and powering innovation since its inception in 1978. Today, CCC supports a thriving knowledge economy as a trusted intermediary, providing licensing solutions that make copyright work, including collective licensing solutions for the use of copyrighted materials with AI systems. CCC also offers a portfolio of innovative and complementary software solutions, as well as high-quality content, data, and information services.

About AVAYL
AVAYL is a pioneering technology company driving innovation in Medical Affairs with AI-native workflow systems. Its core product, MedPro, empowers Medical Affairs teams by applying Artificial Intelligence in Medical Affairs workflows while following scientific principles and regulatory requirements. Trusted by leading life science companies, AVAYL helps manage the growing volume of medical evidence with speed and precision. Learn more about AVAYL at www.avayl.tech.

For more information, please contact:
Craig Sender
Senior Director, Public & Analyst Relations
csender@copyright.com
+1 (917) 626-7152

Simon Desiere
CFO & COO
Simon.desiere@avayl.tech
+49 176 76700506